05:48 PM EDT, 05/20/2025 (MT Newswires) -- Saurabh Saha, Director, Chief Executive Officer, on May 20, 2025, sold 55,000 shares in Centessa Pharmaceuticals ( CNTA ) for $699,111. Following the Form 4 filing with the SEC, Saha has control over a total of 259,017 common shares of the company, with 221,017 shares held directly and 38,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1847903/000184790325000076/xslF345X05/wk-form4_1747777437.xml